XSTO
INQ
Market cap21mUSD
Sep 28, Last price
0.19SEK
Name
Anoto Group AB
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Anoto Group AB (publ) provides digital writing and drawing solutions worldwide. It operates through three segments: Enterprise Solutions (B2B), Retail(B2C), and OEM. The company offers ACE, a cloud-based forms system that provide paper document handling and business process automation for enterprises; Anoto DNA, an interactive security and marketing solution; and Dr. Watson, a biometric authentication and security solution. It also provides KAIT Smart Assessment solution, an AI solution for offline education; and designs and manufactures smart pens under the Livescribe, Dr. Watson, and Anoto Digital Pen names, which digitizes and stores various handwritten information. Anoto Group AB (publ) was incorporated in 1996 and is headquartered in Stockholm, Sweden.
Key people
Kevin Adeson
Independent Chairman of the Board · since 2024
Mats Karlsson
Interim Chief Executive Officer · since 2024
Julia Arnold
Chief Operating Officer · since 2024
Steve Kim
Chief Technology Officer · since 2018
James Kennedy
Chief Marketing Officer · since 2024
Matthew Doerner
Director · since 2025
Alexander Fallstrom
Director · since 2024
Gary Stolkin
Director · since 2024
Adrian Weller
Director · since 2024
Headquarters & legal address
Flaggan 1165
Stockholm 116 74
SE
Stockholm 116 74
SE
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||